Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review

American Journal of Epidemiology

Volumn 155, Issue 6, 2002, Pages 487-495

  Eichner, June E ^a   Dunn, S Terence ^b   Perveen, Ghazala ^a   Thompson, David M ^a   Stewart, Kenneth E ^a   Stroehla, Berrit C ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoproteins E; Cardiovascular diseases; Epidemiology; Genetics

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; APOLIPOPROTEIN E RECEPTOR; CHOLESTEROL; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; GENETICS;

ALLELE; ALZHEIMER DISEASE; ARTERY DISEASE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHROMOSOME 19Q; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; METABOLIC REGULATION; PREDICTION; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW; STROKE;

ALLELES; ANIMALS; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHROMOSOMES, HUMAN, PAIR 19; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPE; HUMANS; LIPOPROTEINS; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; VARIATION (GENETICS);

EID: 0037087052     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/155.6.487     Document Type: Review

References (80)

1. Structure and evolution of the apolipoprotein multigene family
2. Localization of genes encoding apolipoprotein CI, CII, and E to the p13->cen region of human chromosome 19
3. Human apolipoprotein E: The complete amino acid sequence
4. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
5. Human E apoprotein heterogeneity: Cysteine-arginine interchanges in the amino acid sequence of the apo E isoforms
6. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas
7. Apolipoprotein E: An important gene and protein to follow in laboratory medicine
8. Apolipoprotein E polymorphism and atherosclerosis
9. Genetic studies of human apolipoproteins VI. Common polymorphism of apolipoprotein E in blacks
10. Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults: The CARDIA Study. Coronary Artery Risk Development in Young Adults
11. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes: The Strong Heart Study
12. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: Results from the Framingham Offspring Study
13. Apolipoprotein E polymorphism and hyperlipidemia
14. Apolipoprotein E phenotypes in Finnish youths: A cross-sectional and 6-year follow-up study
15. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: The ECTIM Study
16. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults
17. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men
18. Increased frequencies of apolipoprotein ε2 and ε4 alleles in patients with ischemic heart disease
19. Two-dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese
20. Introduction: Structure and metabolism of plasma lipoproteins
21. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E
22. The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations
23. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease
24. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation
25. WHO MONICA Project: Objectives and design
26. A survey of 246 suggested coronary risk factors
27. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
28. Aetiology of peripheral atherosclerosis
29. Genetics of variability of CHD risk
30. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E
31. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease
32. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiography verified coronary artery disease in men and women
33. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men
34. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography
35. Apolipoprotein E polymorphism in health and disease
36. Modulation of plasma triglycerides levels by apoE phenotype: A meta-analysis
37. Apolipoprotein E serum concentration and polymorphism in six European countries: The ApoEurope Project
38. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man
39. Type III hyperlipoproteinemia (dysbetalipoproteinemia) the role of apolipoprotein E in normal and abnormal lipoprotein metabolism
40. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
41. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia
42. The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study IX
43. Apolipoprotein E allele frequencies in non-insulin-dependent diabetes mellitus with hypertriglyceridemia (type IIb, III, IV, and V hyperlipoproteinemia
44. Association of apolipoprotein ε2 allele with diabetic nephropathy in Caucasian subjects with IDDM
45. Apolipoprotein E ε4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia
46. High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis
47. Apolipoprotein E and Alzheimer's disease: The tip of the susceptibility iceberg
48. Apolipoprotein E4 in Parkinson disease and dementia: New data and meta-analysis of published studies
49. Apolipoprotein E genotype and schizophrenia
50. Psychotic symptoms and apolipoprotein E genotypes in an elderly population
51. Apolipoprotein E polymorphism and its association with serum lipoprotein concentrations in black versus white children: The Bogalusa Heart Study
52. Apolipoprotein E polymorphisms affect atherosclerosis in young males
53. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: An autopsy study
54. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis
55. Role of factor V Leiden mutation in patients with angiographically demonstrated coronary artery disease
56. Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients
57. The apolipoprotein ε allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction. A substudy of the Scandinavian Simvastatin Survival Study
58. Aging and genetic variation of plasma apolipoproteins: Relative loss of the apolipoprotein E4 phenotype in centenarians
59. Genetic associations with human longevity at the APOE and ACE loci
60. Lipoprotein and apolipoprotein profile in men with ischemic stroke: Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism
61. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: A case-control study
62. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects
63. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease: A meta-analysis
64. Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know
65. 4 homozygosity predisposes to serum cholesterol elevation during high fat diet
66. Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol
67. Regional serum cholesterol differences in Belgium: Do genetically determined cardiovascular risk factors contribute?
68. Gene-diet interaction in determining plasma lipid response to dietary intervention
69. Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol
70. ApoE genotype does not predict lipid response to changes in dietary saturated fatty acids in a heterogeneous normolipidemic population. Dietary effects on lipoproteins and thrombogenic activity
71. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apo E phenotypes
72. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty
73. The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and young adults: The Cardiovascular Risk in Young Finns Study
74. Apolipoprotein E polymorphism and plasma cholesterol response to probucol
75. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: Prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin
76. Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia
77. Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus
78. Apolipoprotein E to B ratio: A marker for type III hyperlipoproteinaemia
79. Apolipoprotein E polymorphism and coronary artery disease